JT lifts profit and dividend outlook as overseas tobacco booms, but regulation bites
Full-year profit and dividend guidance raised JT lifted its full-year net profit forecast to 644 billion yen, above analyst consensus, and raised the annual dividend to 272 yen. Stronger overseas cigarette sales drove the upgrade, giving investors more confidence in cash returns and supporting the share price.
This is the core new event that re-rated the stock this period.
Interim results show broad revenue and profit growth First-half revenue rose 17.7% and net profit jumped 35%, with tobacco revenue and profit up in every region, led by a 25.2% gain in Europe, the Middle East and Africa. The results confirmed the upgrade was backed by real sales, not accounting, and pushed shares to record highs.
It shows the fundamental business strength behind the guidance raise.
US regulatory edge goes to rival ZYN The FDA gave Philip Morris's ZYN pouches modified-risk status, the first for a nicotine pouch. That lets ZYN market itself as less harmful, while JT's competing pouches lack that label, putting JT at a disadvantage in the fast-growing US smoke-free category.
It is a new competitive and regulatory setback for JT's next-generation products.
Tougher tobacco rules and goodwill risk flagged The UK passed a bill banning cigarette sales to anyone born after 2009, a long-term threat to JT's customer base there. Analysts also note goodwill equals 34.4% of total assets, so any writedown could hit reported profit and temper the strong share run.
It is the main counterweight investors should weigh against the bullish guidance.